{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:37:29Z","timestamp":1778657849701,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s disease (HD) is a monogenetic neurodegenerative disorder that is caused by the expansion of a polyglutamine region within the huntingtin (HTT) protein, but there is still an incomplete understanding of the molecular mechanisms that drive pathology. Expression of the mutant form of HTT is a key aspect of diseased tissues, and the most promising therapeutic approaches aim to lower expanded HTT levels. Consequently, the investigation of HTT expression in time and in multiple tissues, with assays that accurately quantify expanded and non-expanded HTT, are required to delineate HTT homeostasis and to best design and interpret pharmacodynamic readouts for HTT lowering therapeutics. Here we evaluate mutant polyglutamine-expanded (mHTT) and polyglutamine-independent HTT specific immunoassays for validation in human HD and control fibroblasts and use to elucidate the CSF\/brain and peripheral tissue expression of HTT in preclinical HD models.<\/jats:p>","DOI":"10.1038\/s41598-020-78790-5","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T11:07:12Z","timestamp":1608203232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Analysis of mutant and total huntingtin expression in Huntington\u2019s disease murine models"],"prefix":"10.1038","volume":"10","author":[{"given":"Valentina","family":"Fodale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Pintauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Daldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Altobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carolina","family":"Spiezia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Bisbocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bresciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"78790_CR1","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72, 971\u201383 (1993).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"78790_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1055\/s-2008-1040853","volume":"19","author":"BR Leavitt","year":"1999","unstructured":"Leavitt, B. R., Wellington, C. L. & Hayden, M. R. Recent insights into the molecular pathogenesis of Huntington disease. Semin. Neurol. 19, 385\u2013395 (1999).","journal-title":"Semin. Neurol."},{"key":"78790_CR3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F D\u00e9","year":"2016","unstructured":"D\u00e9, F., Saudou, R. & Humbert, S. The biology of huntingtin. Neuron 89, 910\u2013926 (2016).","journal-title":"Neuron"},{"key":"78790_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/978-1-4939-7825-0_23","volume":"1780","author":"RM Lane","year":"2018","unstructured":"Lane, R. M. et al. Translating antisense technology into a treatment for Huntington\u2019s disease. Methods Mol. Biol. 1780, 497\u2013523 (2018).","journal-title":"Methods Mol. Biol."},{"key":"78790_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/mds.26020","volume":"29","author":"N Aronin","year":"2014","unstructured":"Aronin, N. & DiFiglia, M. Huntingtin-lowering strategies in Huntington\u2019s disease: antisense oligonucleotides, small RNAs, and gene editing. Mov. Disord. 29, 1455\u20131461 (2014).","journal-title":"Mov. Disord."},{"key":"78790_CR6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316 (2019).","journal-title":"N. Engl. J. Med."},{"key":"78790_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2017.09.040","volume":"171","author":"RG Yau","year":"2017","unstructured":"Yau, R. G. et al. Assembly and function of heterotypic ubiquitin chains in cell-cycle and protein quality control. Cell 171, 918-933.e20 (2017).","journal-title":"Cell"},{"key":"78790_CR8","doi-asserted-by":"publisher","first-page":"E10809","DOI":"10.1073\/pnas.1705372114","volume":"114","author":"C Cariulo","year":"2017","unstructured":"Cariulo, C. et al. Phosphorylation of huntingtin at residue T3 is decreased in Huntington\u2019s disease and modulates mutant huntingtin protein conformation. Proc. Natl. Acad. Sci. 114, E10809\u2013E10818 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"78790_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/ncb3101","volume":"17","author":"Y-N Rui","year":"2015","unstructured":"Rui, Y.-N. et al. Huntingtin functions as a scaffold for selective macroautophagy. Nat. Cell Biol. 17, 262\u2013275 (2015).","journal-title":"Nat. Cell Biol."},{"key":"78790_CR10","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/s41598-018-25903-w","volume":"8","author":"DDO Martin","year":"2018","unstructured":"Martin, D. D. O. et al. A human huntingtin SNP alters post-translational modification and pathogenic proteolysis of the protein causing Huntington disease. Sci. Rep. 8, 8096 (2018).","journal-title":"Sci. Rep."},{"key":"78790_CR11","doi-asserted-by":"publisher","first-page":"19238","DOI":"10.1074\/jbc.M117.782300","volume":"292","author":"N Arbez","year":"2017","unstructured":"Arbez, N. et al. Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity. J. Biol. Chem. 292, 19238\u201319249 (2017).","journal-title":"J. Biol. Chem."},{"key":"78790_CR12","doi-asserted-by":"publisher","first-page":"12166","DOI":"10.1038\/srep12166","volume":"5","author":"AL Southwell","year":"2015","unstructured":"Southwell, A. L. et al. Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression. Sci. Rep. 5, 12166 (2015).","journal-title":"Sci. Rep."},{"key":"78790_CR13","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41591-019-0478-3","volume":"25","author":"B Zeitler","year":"2019","unstructured":"Zeitler, B. et al. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington\u2019s disease. Nat. Med. 25, 1131\u20131142 (2019).","journal-title":"Nat. Med."},{"key":"78790_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-160196","volume":"5","author":"LM Byrne","year":"2016","unstructured":"Byrne, L. M. & Wild, E. J. Cerebrospinal fluid biomarkers for Huntington\u2019s disease. J. Huntingtons Dis. 5, 1\u201313 (2016).","journal-title":"J. Huntingtons Dis."},{"key":"78790_CR15","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","volume":"26","author":"MM Evers","year":"2018","unstructured":"Evers, M. M. et al. AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a huntington\u2019s disease minipig model. Mol. Ther. 26, 2163\u20132177 (2018).","journal-title":"Mol. Ther."},{"key":"78790_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","volume":"395","author":"A Weiss","year":"2009","unstructured":"Weiss, A. et al. Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington\u2019s disease. Anal. Biochem. 395, 8\u201315 (2009).","journal-title":"Anal. Biochem."},{"key":"78790_CR17","doi-asserted-by":"publisher","first-page":"e0189891","DOI":"10.1371\/journal.pone.0189891","volume":"12","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss, D. J. et al. Quantification of huntingtin protein species in Huntington\u2019s disease patient leukocytes using optimised electrochemiluminescence immunoassays. PLoS ONE 12, e0189891 (2017).","journal-title":"PLoS ONE"},{"key":"78790_CR18","doi-asserted-by":"publisher","first-page":"e96854","DOI":"10.1371\/journal.pone.0096854","volume":"9","author":"D Macdonald","year":"2014","unstructured":"Macdonald, D. et al. Quantification assays for total and polyglutamine-expanded huntingtin proteins. PLoS ONE 9, e96854 (2014).","journal-title":"PLoS ONE"},{"key":"78790_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JHD-170269","volume":"6","author":"V Fodale","year":"2017","unstructured":"Fodale, V. et al. Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay. J. Huntingtons Dis. 6, 349\u2013361 (2017).","journal-title":"J. Huntingtons Dis."},{"key":"78790_CR20","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild, E. J. et al. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients. J. Clin. Invest. 125, 1979\u20131986 (2015).","journal-title":"J. Clin. Invest."},{"key":"78790_CR21","doi-asserted-by":"publisher","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","volume":"32","author":"L Yu-Taeger","year":"2012","unstructured":"Yu-Taeger, L. et al. A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. J. Neurosci. 32, 15426\u201315438 (2012).","journal-title":"J. Neurosci."},{"key":"78790_CR22","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled, L. B. et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7, e49838 (2012).","journal-title":"PLoS ONE"},{"key":"78790_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.chembiol.2011.12.020","volume":"19","author":"B Baldo","year":"2012","unstructured":"Baldo, B. et al. TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in Huntington\u2019s disease. Chem. Biol. 19, 264\u2013275 (2012).","journal-title":"Chem. Biol."},{"key":"78790_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","volume":"56","author":"J Ko","year":"2001","unstructured":"Ko, J., Ou, S. & Patterson, P. H. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain Res. Bull. 56, 319\u201329 (2001).","journal-title":"Brain Res. Bull."},{"key":"78790_CR25","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1038\/s41598-017-05336-7","volume":"7","author":"M Daldin","year":"2017","unstructured":"Daldin, M. et al. Polyglutamine expansion affects huntingtin conformation in multiple Huntington\u2019s disease models. Sci. Rep. 7, 5070 (2017).","journal-title":"Sci. Rep."},{"key":"78790_CR26","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","volume":"3","author":"LS Kaltenbach","year":"2007","unstructured":"Kaltenbach, L. S. et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82 (2007).","journal-title":"PLoS Genet."},{"key":"78790_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0169-328X(99)00097-2","volume":"69","author":"FL Wilkinson","year":"1999","unstructured":"Wilkinson, F. L. et al. Localization of rabbit huntingtin using a new panel of monoclonal antibodies. Brain Res. Mol. Brain Res. 69, 10\u201320 (1999).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"78790_CR28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato, C., Valenza, M. & Cattaneo, E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol. Rev. 90, 905\u2013981 (2010).","journal-title":"Physiol. Rev."},{"key":"78790_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fneur.2015.00179","volume":"6","author":"U Andreasson","year":"2015","unstructured":"Andreasson, U. et al. A practical guide to immunoassay method validation. Front. Neurol. 6, 179 (2015).","journal-title":"Front. Neurol."},{"key":"78790_CR30","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jpba.2011.03.033","volume":"55","author":"M-A Valentin","year":"2011","unstructured":"Valentin, M.-A., Ma, S., Zhao, A., Legay, F. & Avrameas, A. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies. J. Pharm. Biomed. Anal. 55, 869\u2013877 (2011).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"78790_CR31","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1023\/B:PHAM.0000003390.51761.3d","volume":"20","author":"B DeSilva","year":"2003","unstructured":"DeSilva, B. et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20, 1885\u20131900 (2003).","journal-title":"Pharm. Res."},{"key":"78790_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1098\/rstb.1999.0447","volume":"354","author":"K Sathasivam","year":"1999","unstructured":"Sathasivam, K. et al. Transgenic models of Huntington\u2019sdisease. Philos. Trans. R Soc. B. Biol. Sci. 354, 963\u2013969 (1999).","journal-title":"Philos. Trans. R Soc. B. Biol. Sci."},{"key":"78790_CR33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow, E. J. et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12, 1555\u20131567 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"78790_CR34","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen, T. et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 7, e50717 (2012).","journal-title":"PLoS ONE"},{"key":"78790_CR35","doi-asserted-by":"publisher","first-page":"e0213521","DOI":"10.1371\/journal.pone.0213521","volume":"14","author":"W Reindl","year":"2019","unstructured":"Reindl, W. et al. Meso scale discovery-based assays for the detection of aggregated huntingtin. PLoS ONE 14, e0213521 (2019).","journal-title":"PLoS ONE"},{"key":"78790_CR36","doi-asserted-by":"publisher","first-page":"e0121055","DOI":"10.1371\/journal.pone.0121055","volume":"10","author":"B Huang","year":"2015","unstructured":"Huang, B. et al. Scalable production in human cells and biochemical characterization of full-length normal and mutant huntingtin. PLoS ONE 10, e0121055 (2015).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78790-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78790-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78790-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:50:20Z","timestamp":1670374220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78790-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78790"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78790-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22137"}}